Per Harry Rutger Lindström

Title: Per Harry Rutger Lindström: Innovator in Cardiovascular Assessment

Introduction

Per Harry Rutger Lindström is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of cardiovascular health through his innovative methods and compositions. His work focuses on assessing cardiovascular status, which is crucial for early detection and treatment of heart-related conditions.

Latest Patents

Lindström holds a patent for "Methods for assessing cardiovascular status and compositions for use thereof." This invention provides methods for assessing cardiovascular status in an individual by determining the sequence at one or more polymorphic positions within the human genes encoding angiotensin converting enzyme (ACE), angiotensinogen (AGT), and/or type 1 angiotensin II receptor (AT1). The patent also includes isolated nucleic acids encoding ACE, AGT, and AT1 polymorphisms, nucleic acid probes that hybridize to polymorphic positions, kits for predicting cardiovascular status, and nucleic acid and peptide targets for identifying candidate cardiovascular drugs. He has 1 patent to his name.

Career Highlights

Lindström is associated with Pyrosequencing AB, a company that specializes in innovative sequencing technologies. His work at the company has allowed him to contribute to advancements in genetic testing and cardiovascular health assessment.

Collaborations

Some of his notable coworkers include Leif Torbjörn Norberg and Maria Kristina Andersson. Their collaborative efforts have further enhanced the research and development of cardiovascular assessment methods.

Conclusion

Per Harry Rutger Lindström is a pioneering inventor whose work in cardiovascular assessment has the potential to improve health outcomes significantly. His innovative methods and compositions are vital for advancing the understanding and treatment of cardiovascular diseases.